Brefanolol

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBrefanolol
Drug Alias Namebrefonalolum布福洛尔BrefonalolBDF-8186
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonistsAdrenergic receptor alpha-1 antagonists
TargetsBeta adrenergic receptorsAdrenergic receptors alpha-1
Therapy Area/IndicationsHypertensionAngina PectorisArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBeiersdorf Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeiersdorf Ag
Active IndicationsN/A
Inactive IndicationsHypertensionAngina PectorisArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksWikipedia